Evolus Announces FDA Approval of Two Injectable Hyaluronic Acid Gels
Evolus secures FDA approval for Evolysse Form and Evolysse Smooth, set to launch in Q2 2025 with advanced Cold-X technology.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
